Canature Health Technology Group Co. Ltd. said its third-quarter normalized net income was 4 fen per share, a decline from 4 fen per share in the prior-year period.
Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 16.4 million yuan, a decline from 16.7 million yuan in the prior-year period.
The normalized profit margin declined to 9.6% from 15.6% in the year-earlier period.
Total revenue rose 58.6% on an annual basis to 170.0 million yuan from 107.2 million yuan, and total operating expenses grew 67.4% on an annual basis to 146.4 million yuan from 87.5 million yuan.
Reported net income increased 6.7% year over year to 25.3 million yuan, or 6 fen per share, from 23.7 million yuan, or 6 fen per share.
As of Oct. 25, US$1 was equivalent to 6.78 yuan.